Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

In vivo glutamate clearance defects in a mouse model of Lafora disease.

Muñoz-Ballester C, Santana N, Perez-Jimenez E, Viana R, Artigas F, Sanz P.

Exp Neurol. 2019 May 18;320:112959. doi: 10.1016/j.expneurol.2019.112959. [Epub ahead of print]

PMID:
31108086
2.

Isolation of Lysosomes from Mammalian Tissues and Cultured Cells.

Aguado C, Pérez-Jiménez E, Lahuerta M, Knecht E.

Methods Mol Biol. 2016;1449:299-311. doi: 10.1007/978-1-4939-3756-1_19.

PMID:
27613045
3.

CERKL, a retinal disease gene, encodes an mRNA-binding protein that localizes in compact and untranslated mRNPs associated with microtubules.

Fathinajafabadi A, Pérez-Jiménez E, Riera M, Knecht E, Gonzàlez-Duarte R.

PLoS One. 2014 Feb 3;9(2):e87898. doi: 10.1371/journal.pone.0087898. eCollection 2014.

4.

Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Sánchez-Sampedro L, Gómez CE, Mejías-Pérez E, Pérez-Jiménez E, Oliveros JC, Esteban M.

J Virol. 2013 Jun;87(12):6955-74. doi: 10.1128/JVI.03013-12. Epub 2013 Apr 17.

5.

Glucose induces autophagy under starvation conditions by a p38 MAPK-dependent pathway.

Moruno-Manchón JF, Pérez-Jiménez E, Knecht E.

Biochem J. 2013 Jan 15;449(2):497-506. doi: 10.1042/BJ20121122.

PMID:
23116132
6.

Regulation of autophagy by glucose in Mammalian cells.

Moruno F, Pérez-Jiménez E, Knecht E.

Cells. 2012 Jul 27;1(3):372-95. doi: 10.3390/cells1030372.

7.

Caspase 8 inhibits programmed necrosis by processing CYLD.

O'Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, Xavier R, Green DR, Ting AT.

Nat Cell Biol. 2011 Oct 30;13(12):1437-42. doi: 10.1038/ncb2362.

8.

Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Dondji B, Deak E, Goldsmith-Pestana K, Perez-Jimenez E, Esteban M, Miyake S, Yamamura T, McMahon-Pratt D.

Eur J Immunol. 2008 Mar;38(3):706-19. doi: 10.1002/eji.200737660.

9.

Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Domingo-Gil E, Pérez-Jiménez E, Ventoso I, Nájera JL, Esteban M.

J Virol. 2008 Jan;82(1):254-67. Epub 2007 Oct 24.

10.

MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis.

Pérez-Jiménez E, Kochan G, Gherardi MM, Esteban M.

Microbes Infect. 2006 Mar;8(3):810-22. Epub 2006 Jan 13.

PMID:
16504562
11.

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis.

Dondji B, Pérez-Jimenez E, Goldsmith-Pestana K, Esteban M, McMahon-Pratt D.

Infect Immun. 2005 Aug;73(8):5286-9.

15.

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice.

López-Fuertes L, Pérez-Jiménez E, Vila-Coro AJ, Sack F, Moreno S, Konig SA, Junghans C, Wittig B, Timón M, Esteban M.

Vaccine. 2002 Dec 13;21(3-4):247-57.

PMID:
12450700

Supplemental Content

Loading ...
Support Center